Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 5.37 is 269% above its 5-year average of -3.18, near the high end of its 5-year range (-6.08–5.37).
292.47% above its 12-month average of -2.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 6.28.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:24.504Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
5.37
EARNINGS PER SHARE (EPS) AVG TTM
-2.79
EARNINGS PER SHARE (EPS) AVG 3Y
-4.06
EARNINGS PER SHARE (EPS) AVG 5Y
-3.18
EARNINGS PER SHARE (EPS) AVG 10Y
-2.48
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+292.47%
CURRENT VS 3Y AVG
+232.35%
CURRENT VS 5Y AVG
+268.96%
CURRENT VS 10Y AVG
+316.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
AnaptysBio, Inc.
Market Cap
$1.46B
Earnings Per Share (EPS)
5.37
TTM Avg
-2.79
3Y Avg
-4.06
5Y Avg
-3.18
Market Cap
$1.45B
Earnings Per Share (EPS)
1.71
TTM Avg
0.68
3Y Avg
0.58
5Y Avg
0.72
Market Cap
$1.43B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.33
3Y Avg
-2.33
5Y Avg
-2.33
Market Cap
$1.51B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.40B
Earnings Per Share (EPS)
N/A
TTM Avg
-1.26
3Y Avg
-1.26
5Y Avg
-1.26
Market Cap
$1.52B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
Market Cap
$1.52B
Earnings Per Share (EPS)
4.10
TTM Avg
2.19
3Y Avg
2.59
5Y Avg
2.64
Market Cap
$1.52B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.39B
Earnings Per Share (EPS)
-8.88
TTM Avg
53.77
3Y Avg
24.70
5Y Avg
19.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.46B | 5.37 | -2.79 | -4.06 | -3.18 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 1.71 | 0.68 | 0.58 | 0.72 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | N/A | -2.33 | -2.33 | -2.33 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | N/A | -1.26 | -1.26 | -1.26 |
| GH Research PLC (GHRS)vs › | $1.52B | -1.00 | -0.77 | -0.59 | -0.43 |
| Innoviva, Inc. (INVA)vs › | $1.52B | 4.10 | 2.19 | 2.59 | 2.64 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.38 | -0.16 | -0.18 | -0.35 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -8.88 | 53.77 | 24.70 | 19.33 |
| Kardigan, Inc. (KARD)vs › | $1.36B | N/A | -3.20 | -3.20 | -3.20 |
Trailing EPS (TTM)
$5.37
Forward EPS (Est.)
$-2.28
P/E Ratio
9.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.46 |
| 2024-12-31 | -5.12 |
| 2023-12-31 | -6.08 |
| 2022-12-31 | -4.57 |
| 2021-12-31 | -2.11 |
| 2020-12-31 | -0.73 |
| 2019-12-31 | -3.60 |
| 2018-12-31 | -2.50 |
| 2017-12-31 | -1.52 |
| 2016-12-31 | -0.23 |
| 2015-12-31 | -0.38 |
| 2014-12-31 | 0.24 |
| 2013-12-31 | -2.28 |
